Zobrazeno 1 - 10
of 84
pro vyhledávání: '"G. Blekkenhorst"'
Publikováno v:
Strahlentherapie und Onkologie. 174:75-81
To assess the suitability of the cytokinesis block micronucleus assay as a biological dosimeter following in-vivo radiation using cancer patients undergoing radiotherapy.Blood from 4 healthy donors was irradiated in vitro with gamma-rays and the dose
Publikováno v:
Radiation Oncology Investigations. 4:255-260
Publikováno v:
Radiation Oncology Investigations. 3:151-156
The substituted benzaldehyde BW12C has previously been shown to decrease tumor oxygenation. This, in turn, was linked to the drug's ability to alter the affinity of hemoglobin for oxygen and/or to change tumor blood flow. In the present study, the ab
Autor:
A. Hendrikse, G. Blekkenhorst
Publikováno v:
Radiation Oncology Investigations. 2:171-176
The tumor cytotoxic activity of a bioreductive agent is dependent on the extent of tumor hypoxia. It is to be expected, therefore, that the tumor cytotoxicity of misonidazole will vary depending on whether it was administered to mice exposed only to
Publikováno v:
International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology. 18:855-858
The synthesis and T1 and T2 relaxivities of the Cr(III)-(NH2)-Sar-cage complex is reported. An outer-sphere relaxation mechanism is postulated for the relaxivity of the complex. Tissue distribution studies in mice using a [57Co]cobalt analogue as a r
Autor:
Charles Kent, G. Blekkenhorst
Publikováno v:
Free Radical Research Communications. 13:595-599
Superoxide dismutase (SOD) is known to protect cells from the lethal effects of ionizing radiation by the dismutation of oxygen radicals. Diethyldithiocarbamate (DDC) is known inhibitor of SOD and may therefore be useful as a radiosensitizer. DDC how
Publikováno v:
Health physics. 78(6)
Publikováno v:
International journal of radiation oncology, biology, physics. 32(1)
Purpose: The purpose of this work was to measure blood flow in tumors using a coincide counting technique on patients undergoing treatment with neutrons. Methods and Materials: The half-time, T w , for the washout of 15 O from neutron-activated tumor
Publikováno v:
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]. 171(1)
Beam availability for neutron therapy at the National Accelerator Centre at Faure, South Africa is such that treatment fractions are given at irregularly spaced intervals. Such treatment scheduling may not be optimal.Investigations were made using th